Litcius/Paper detail

Non-viral siRNA delivery to T cells: Challenges and opportunities in cancer immunotherapy

Jelter Van Hoeck, Kevin Braeckmans, Stefaan C. De Smedt, Koen Raemdonck

2022Biomaterials34 citationsDOI

Topics & Concepts

ImmunotherapyCancer immunotherapySmall interfering RNAT cellImmune systemImmune checkpointCancer researchCancerAdoptive cell transferBiologyTransfectionImmunologyCell cultureGeneticsRNA Interference and Gene DeliveryCAR-T cell therapy researchImmunotherapy and Immune Responses
Non-viral siRNA delivery to T cells: Challenges and opportunities in cancer immunotherapy | Litcius